ACE2 and inflammatory bowel disease: Furthermore, Burgueno et al. have recently showed that the expression of ACE2 was not increased in patients with IBD and further therapy with biologics may decrease the expression of these receptors, resulting in overall support for a milder course in IBD patients [27].